
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
EBP1 CRISPR/Cas9 KO Plasmid (h) | sc-402177 | 20 µg | $397.00 |
PA2G4 encodes EBP1, an RNA- and protein-binding factor that localizes to both cytoplasm and nucleus and participates in the coordination of gene expression at transcriptional and translational levels. EBP1 has been linked to signaling downstream of receptor tyrosine kinases and to the regulation of cell-cycle progression, proliferation, and differentiation through modulation of mRNA stability, ribosome-associated processes, and transcriptional programs. By influencing growth control pathways and stress-responsive gene expression networks, PA2G4 is frequently studied in the context of oncogenic signaling and other diseases characterized by dysregulated proliferation. Its multifaceted roles make it a useful node for dissecting how growth factor cues are integrated with RNA metabolism and chromatin-associated regulation in human cells.
EBP1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the PA2G4 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the PA2G4 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the PA2G4 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish EBP1 protein expression.
This CRISPR knockout system enables efficient generation of PA2G4-deficient cell models for investigation of EBP1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.